Home/Filings/4/0001140361-22-005100
4//SEC Filing

Stach Mark A 4

Accession 0001140361-22-005100

CIK 0000009326other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 9:15 AM ET

Size

9.8 KB

Accession

0001140361-22-005100

Insider Transaction Report

Form 4
Period: 2022-02-10
Stach Mark A
General Counsel and Secretary
Transactions
  • Award

    Common Stock

    2022-02-10+2,2009,891 total
  • Tax Payment

    Common Stock

    2022-02-10$138.07/sh829$114,4609,062 total
  • Award

    Stock Option

    2022-02-10+2,20018,500 total
    Exercise: $138.07Exp: 2032-02-10Common Stock (2,200 underlying)
  • Award

    Common Stock

    2022-02-10+6507,691 total
Footnotes (4)
  • [F1]Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person.
  • [F2]Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria.
  • [F3]829 of the 2200 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting.
  • [F4]Options vest 20% Year 1; 40% Year 2; and 40% Year 3.

Issuer

BALCHEM CORP

CIK 0000009326

Entity typeother

Related Parties

1
  • filerCIK 0001731179

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 9:15 AM ET
Size
9.8 KB